
==== Front
Sci Rep
Sci Rep
Scientific Reports
2045-2322
Nature Publishing Group UK London

39289449
65762
10.1038/s41598-024-65762-2
Article
Anti-Helicobacter pylori activity of nanocomposites from chitosan/broccoli mucilage/selenium nanoparticles
Aborabu Ahlam A. S. 1
Tayel Ahmed A. ahmed_tayel@fsh.kfs.edu.eg

15
Assas Mona 1
Moussa Shaaban H. shaaban@su.edu.sa

2
Alalawy Adel I. 3
Almutairi Fahad M. 3
Omar Amira A. 4
1 https://ror.org/04a97mm30 grid.411978.2 0000 0004 0578 3577 Department of Fish Processing and Biotechnology, Faculty of Aquatic and Fisheries Sciences, Kafrelsheikh University, Kafrelsheikh, 33516 Egypt
2 https://ror.org/05hawb687 grid.449644.f 0000 0004 0441 5692 Department of Biology, College of Science and Humanitarian Studies, Shaqra University, 11961 Shaqra, Saudi Arabia
3 https://ror.org/04yej8x59 grid.440760.1 0000 0004 0419 5685 Biochemistry Department, Faculty of Science, University of Tabuk, 47512 Tabuk, Saudi Arabia
4 https://ror.org/04a97mm30 grid.411978.2 0000 0004 0578 3577 Department of Fish Diseases and Management, Faculty of Veterinary Medicine, Kafrelsheikh University, Kafrelsheikh, 33516 Egypt
5 https://ror.org/02k284p70 grid.423564.2 0000 0001 2165 2866 Academy of Scientific Research & Technology (ASRT), Cairo, 11516 Egypt
17 9 2024
17 9 2024
2024
14 2169319 3 2024
24 6 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Helicobacter pylori can infect most people worldwide to cause hazardous consequences to health; the bacteria could not easily be controlled or disinfected. Toward exploring of innovative biocidal nanoformulations to control H. pylori, broccoli seeds (Brassica oleracea var. italica) mucilage (MBS) was employed for biosynthesizing selenium nanoparticles (MBS/SeNPs), which was intermingled with chitosan nanoparticles (NCT) to generate bioactive nanocomposites for suppressing H. pylori. The MBS could effectually generate and stabilize SeNPs with 13.61 nm mean diameter, where NCT had 338.52 nm mean diameter and positively charged (+ 39.62 mV). The cross-linkages between NCT-MBS-SeNPs were verified via infrared analysis and the nanocomposites from NCT:MBS/SeNPs at 1:2 (T1), 1:1 (T2) and 2:1 (T3) ratios had mean diameters of 204, 132 and 159 nm, respectively. The entire nanomaterials/composites exhibited potent anti- H. pylori activities using various assaying methods; the T2 nanocomposite was the utmost bactericidal agent with 0.08–0.10 mg/L minimal concentration and 25.9–27.3 mm inhibition zones. The scanning microscopy displayed the ability of nanocomposite to attach the bacterial cells, disrupt their membranes, and completely lyse them within 10 h. The NCT/MBS/SeNPs nanocomposites provided effectual innovative approach to control H. pylori.

Keywords

Antibacterial
Biopolymers
Green synthesis
Helicobacter pylori
Nanoconjugation
Subject terms

Biological techniques
Biotechnology
Microbiology
Nanoscience and technology
issue-copyright-statement© Springer Nature Limited 2024
==== Body
pmcA graphical abstract of the study is illustrated hereafter (Fig. S1).

Introduction

Helicobacter pylori, which in 1994 was categorized by the WHO “World Health Organization” as a group I carcinogen, is a Gram (–), microaerophilic, flagellated, helical bacteria that occupy the human stomach mucosa and duodenum, it is known as one of the most widespread infections globally, particularly within underdeveloped regions, and the primary reason of chronic gastritis, peptic ulcer disorders (PUD), as well as gastric cancer and gastric MALT lymphoma over time1,2. Helicobacter pylori is thought to infect 50–75% of the world’s population. Only one out of every ten people infected with this microbe was marked by the emergence of infection signs, the others are shown to remain asymptomatic carriers3.

Some external factors, such as increases in O2 concentration, changes in pH/temperature, and exposure to antimicrobial agents or any other unfavorable environmental conditions, may create pressure on H. pylori4,5. In order, H. pylori has evolved several morphological and metabolic modifications as a means of adapting to these stressors6.

The transition of H. pylori from its typical spiral-shaped bacillus to a coccoid form is one of the morphological alterations. The coccoid forms of H. pylori are typically in a less virulent, low activity of metabolism state described as VBNC “viable but non-culturable”7. It has been proven that bacteria in the VBNC state are capable of continuing to be pathogenic and can even shift back to active regrowth states. In addition, it has been demonstrated that these forms may defy immune reactions, accelerate the development of cancer, and tolerate high temperatures, lengthy incubation, aerobiosis, and treatments with antibiotics or proton pump inhibitors, and then contributing to the failure of therapy. Therefore, it is crucial to eradicate these forms of H. pylori7–9.

Even though H. pylori was discovered about four decades ago, there is no 100% effective medication10,11. The currently used H. pylori treatment consists of triple or quadruple therapeutic groups such as CTT “clarithromycin triple therapy”, ATT “amoxicillin triple therapy”, BQT “bismuth quadruple therapy”, and NBQT “nonbismuth quadruple therapy”. However, with the emergence of drug-resistant strains, a resistance rate of 20% to CTT and ATT and around 30% to BQT appeared12–14. According to the WHO, H. pylori ranks among the top 12 antibiotic-resistant bacteria that need to be targeted for drug development15.

Finding more efficient, safe, and affordable treatments has become increasingly crucial to overcome the pathogenicity of antibiotic-resistant H. pylori16,17. Plant compounds with anti- H. pylori action have been the subject of numerous studies18. It has been discovered that antibacterials derived from plant seeds can successfully suppress or limit microorganisms and address antibiotic resistance19. Naturally occurring plant-based biopolymers (glucans, gums, mucilage, and cellulose) are useful components for creating affordable, environmentally beneficial products. Plantaginaceae, Linaceae, Acanthaceae, and Brassicaceae are the families of plants that produce mucilage from their seed coats20. Compounds having antiviral, antibacterial, and anticancer activities are especially abundant in plants in the Brassicaceae family21. Among its relatives, broccoli has the largest quantity of secondary metabolites including phenolic compounds, flavonoids, and sulforaphane. Moreover, it has been reported that seeds contain the highest concentration of sulforaphane, an antibacterial agent that inhibits H. pylori22.

One of the more recent transdisciplinary areas that have significantly improved a range of applications is nanotechnology. A branch of nanotechnology called nanobiotechnology works with lifeforms to generate and manipulate nanoparticles (NPs)23. Metallic NPs have been extensively utilized in several biological fields, including as antibacterial, antioxidant, and anticoagulant agents. Due to its remarkable physicochemical qualities, which include little toxicity, chemical stability, and biocompatibility, selenium nanoparticles (SeNPs), have garnered a lot of attention24,25. It also has a broad variety of uses in the biomedical sector26. Because of their controllability, eco-friendliness, high yield, and affordability, green synthesized SeNPs have benefits over conventional physical and chemical procedures in the synthesis of nanomaterials of diverse sizes, shapes, and biological types27,28. Recently, SeNPs have proven to exhibit potent antibacterial activity against pathogenic microorganisms29.

The biopolymers have demonstrated enhanced superiority when it comes to their potential for use in drug encapsulation, or carrying applications30. Chitosan is a positively charged biopolymer molecule that is obtained from the bioactive deacetylated form of chitin. It may be effectively acquired from a variety of sources that include the skeletons of insects, fungi, and crustacean wastes27,31,32. Chitosan offers several benefits, including its antibacterial activity, mucoadhesivity, remarkable biocompatibility and biodegradability, nontoxicity, and low allergenicity33,34. Comparing chitosan in nanoform to bulk materials, it has been demonstrated to increase biopolymer bioactivities (such as drug transport, anticancer, antibacterial, toxicant adsorption, bioremediation, nanometals conjugation, and antioxidant and anti-inflammatory properties). One of the most adaptable polymers for the creation of antimicrobial chemotherapies in therapeutic research is chitosan nanoparticles (NCT), which have demonstrated strong antibacterial activity against a variety of microbes29,35. The most common theory regarding chitosan’s antibacterial activity is that the electrostatic force between positively charged chitosan and negatively charged bacteria cell walls encourages a closer interaction, disrupting the cell and changing the permeability of the membrane, which allows the drug to pass through the bacteria cell wall. then attaches itself to DNA, inhibiting DNA replication and ultimately leading to cell death33,36.

Consequently, the key goal of this research is to characterize and ascertain the effect of the nanocomposites built from greenly synthesized SeNPs from broccoli seed mucilage with NCT against H. pylori.

Materials and methods

The “Agricultural Research Center, Giza, Egypt” is where the broccoli “Brassica oleracea var. italica” seeds were attained. Unless specified otherwise, all used chemicals, media, and reagents were purchased from Sigma-Aldrich Co. (St. Louis, MO, United States). All methods were carried out in accordance with relevant guidelines.

Mucilage of broccoli seeds (MBS)

The seeds were thoroughly ground into a fine powder using a porcelain mortar before being soaked in distilled water (DW) at a 1:20 (w/v) ratio with continually stirred using a magnetic stirrer (650 × g) for 6 h at room temperature, then the mixture was filtered using a pair of filter paper (6 mm Ø). Ethanol (96%) was added to the filtrate in a 1:1 ethanol to filtrate ratio to obtain the mucilage at 3–4 °C for 3 h. When the mucilage precipitates, it is separated through centrifugation (4800 × g) and dried by vacuum drying oven at a temperature of 42 °C until the mucilage is completely dried.

Green-synthesis of SeNPs

An aqueous solution of sodium selenite (Na2SeO3) was prepared (0.17 g Na2SeO3 for every 100 ml of distilled water). for green synthesis of SeNPs, an equal volume of both aqueous solutions of MBS (0.1%, w/v) and sodium selenite were held on a magnetic stirrer (650 × g for 90 min) with the addition of Ascorbic acid as a reducing agent until a reddish-orange color change was noticed indicating the synthesis of MBS-SeNPs. Then it collected by centrifuging (10,000 g, 25 min), washed with DW to remove extra materials, centrifuged again, and then was dried.

Preparation and loading of NCT

A solution of chitosan with concentrations of 1% (w/v) was prepared. STPP (sodium tripolyphosphate) solution is dripped very gradually into a 1:1 ratio of chitosan solution and MBS/ SeNPs solution within the continuous magnetic stirring. Then collected by centrifuging, washing with DW, centrifuged again, and drying. Different concentrations of NCT/MBS-SeNPs were made as a study to determine the most effective combination for them, trial (T1) with 1:2 NCT: MBS-SeNPs ratio, trial (T2) with 1:1 NCT: MBS-SeNPs, and 2:1 NCT: MBS-SeNPs ratio for trial (T3).

A schematic diagram of the nanocomposite (NCT/MBS-SeNPs) synthesis process is provided hereafter (Fig. S2).

Characterization of NCT/MBS/SeNPs

FTIR analysis

The “Fourier transform infrared spectroscopy” examinations of the produced compounds powder (NCT, MBS, MBS/SeNPs, NCT/MBS/SeNPs) that were combined with 1% KBr then obtained from wavenumber range of 500–4000 cm−1 by using a FTIR spectroscopy, JASCO FT-IR-360, Tokyo, Japan. To determine the distinctive biochemical bonding/interactions in produced compounds. The resulting peaks were plotted with wavenumber (cm−1) on the X-axis and transmittance (%) on the Y-axis.

The particle sizes (Ps) and superficial charges (zeta potentiality)

Using zetasizer (Zeta plus, Brookhaven, USA), employing the DLS “Dynamic Light Scattering” methodology that analyzes the temporal fluctuations using the intensity/photon autocorrelation function, the Ps and zeta (ζ) potential of the produced nanomaterials or nanocomposites were appraised after dissolving it in DW and sonicated, their Ps/ ζ potentials were recorded between + 150 and − 150 mV at RT.

TEM “transmission electron microscope” and SEM “scanning electron microscope” imaging

The particle size, apparent shape, morphology, and distribution of the produced nanomaterials or NCs were screened using the “scanning electron microscope” (SEM; IT100, JEOL, Tokyo, Japan) and “transmission electron microscope” (TEM; Leica-Leo 0430; Cambridge, UK). For the SEM, DIW suspensions of prepared NCs (T1, T2, T3) were sonicated before inspection. These NC solutions were mounted onto self-adhesive SEM carbon discs, coated by palladium-gold (with Polaron coater: E5100 II, PA), and inspected at 15–20 kV acceleration and 30 kx magnification. The MBS-mediated SeNPs were inspected via TEM after dropping its sonicated solution (0.01%, w/v) onto TEM copper grids, dehydrating with vacuum for 33 min, and exposing to imaging at acceleration of 30 kV.

In vitro determination of antibacterial activity

Experiments, both qualitative and quantitative, were used to demonstrate the antibacterial activity of NCT/MBS/SeNPs against a standard strain of H. pylori (ATCC-700824), and H. pylori isolated from antral biopsy specimens of gastric ulcer patients at Kafr El-Sheikh University Hospital. After sampling, the specimens were minced and homogenized in a sterile saline solution (0.5 mL) before seeding on BHI “brain heart infusion” agar supplemented with 7% defibrinated horse blood. The plates were incubated for at most 10 days under microaerophilic conditions (5% O2, 10% CO2, and 85% N2) at thirty-seven degrees Celsius. Using Gram stain, urease/catalase/oxidase assays, API Campy (automated system mini-API, BioMérieux), and PCR (Eppendorf Thermocycler, Hamburg, Germany), suspected isolates were confirmed as H. pylori37. Assuming the same conditions, Amoxicillin was used as the standardized positive antibacterial.

Qualitative assay

The ZOI assay “zones of inhibition” using the “disc diffusion method” was carried out for preliminary examination of the activity of generated nanocomposites MBS, NCT, MBS/ SeNPs, and NCT/MBS/SeNPs (T1, T2, and T3) against H. pylori. A sterile paper disc (Whatman No. 1, 6 mm Ø) was immersed in a solution of each substance (10% in DIW) and placed onto a BHI plate that was inoculated with H. pylori. After 24–48 h of humid microaerophilic incubation at 37 °C, the ZOI diameters that initially appeared were measured, and their triplicate means were computed18,38.

Quantitative assay

The microdilution procedure was used to assess the MIC “minimum inhibitory concentration” of MBS, NCT, MBS/ SeNPs, and NCT/MBS/SeNPs (T1, T2, and T3) against H. pylori. Each substance was serially concentrated within the range of 10–100 g/mL, then, 1 mL of each solution was added to tubes containing 8 mL of Mueller Hinton broth with 7% of defibrinated horse blood. After that, 1 mL of a 1:1000 dilution of bacteria was added to make an overall volume of 10 ml. A positive control tube was prepared without any of the tested substances under the same conditions. The MIC was evaluated after 2–3 days of microaerophilic incubation at 37 °C37,39.

Microscopic observation of treated H. pylori

Images from SEM (JEOL JSMIT100, Tokyo, Japan) were used to see how the bacterial cells’ morphology and structure changed after being exposed to NCT/MBS/SeNPs for 6–12 h. A standardized procedure was used in the SEM bacterial imaging, 24-h-old grown bacteria in BHI were exposed to 100 μg/mL of composite while being incubated under microaerophilic conditions at 37 °C. Bacterial samples were centrifuged at 4700 g for 30 min, rinsed with NaCl solution, and then centrifuged again before being imaged using SEM. The SEM imaging protocol involved the dehydration of cells via successive ethanol concentrations followed by drying through critical-point drier “Auto-Samdri-815; Tousimis, Rockville, MD” and palladium/gold coating. The images were captured to detect distortions/deformations in cells structures at 20 kV acceleration and 30.000 × magnification.

Statistical analysis

For statistical computation, the SPSS package “V 17.0, SPSS Inc., Chicago, IL” was used. Experiments were carried out in triplicate, and data were reported as means SD. Results’ significances at p ≤ 0.05 were computed using a t-test and one-way ANOVA.

Results

Characterization of NCT/MBS/SeNPs

FTIR analysis

The FTIR spectrum of the NCT, MBS, MBS/ SeNPs, and NCT/MBS/SeNPs determines biological groups, bonds, and the interaction among each other, through assessing the absorbed amount of infrared radiation over a broad spectrum of wavelengths. The extent of chemical composition changes that result from the interaction and interference of materials with each other, confirming the development of a new compound with a new chemical composition, was determined.

In the FTIR spectrum of (NCT) (Fig. 1), the N–H stretching vibrations were identified as the quite wide band at 3422 cm−1, which overlapped the O–H stretching vibrations peak at that same location. The smaller band at 2921 cm−1 is ascribed to the stretching vibrations of chitosan’s –CH and –CH2, which is a typical polysaccharide band. The other absorption bands spotted at 1644 cm−1,1415 cm−1,1386 cm−1,1036 cm−1 are ascribed to stretched C=O in amide I, CH2 bending, CH3 symmetrical deformations and − OH vibrated stretching of C6, in that order30,40–43.Figure 1 FTIR spectra for NCT, MBS, MBS/ SeNPs, and NCT/MBS/SeNPs.

In (Fig. 2) (MBS), Owing to the multiple bioactive compounds observed in broccoli, a peak with a wide width in the range of 3200–3500 cm−1 might be attributed to the stretching vibration of the phenol hydroxyl group, which also overlapped with the amines’ N–H. This is followed by a peak at 2850 cm−1 which has been pinpointed as the methylene symmetric and asymmetric C–H members of the aliphatic group. The bands present at 1749 and 1644 cm−1 reflect to C=O present in carboxylic acids and stretching vibration of carbonyl (C=O bonds derived from ester groups), in that order44–47.Figure 2 TEM image of the green synthesized SeNPs from MBS.

According to the modifications noticed in Fig. 1 (MBS/ SeNPs) compared to the spectrum of (MBS), It appears that the SeNPs affect the bands’ strength, which shifts towards higher wavenumbers. Such as the band 3292 cm−1 which shifts to 3415 cm−1 due to the formation of nanoparticles. The 2915, 2850, and 1250 cm−1 bands appeared with lower intensity/ wideness than they were in the spectrum of (MBS). Bands at 3000, 1749, 1554,1458, 1310, 1144, 702, 626, and 536 m−1 vanished, indicating that these bonds were broken and occupied upon interaction with SeNPs, and other bands newly appeared, for example, at 3850, 1415 and 1332 cm−1, where the band 1415 cm−1 indicate fluoro compounds with C–F stretching46,48.

The (NCT/MBS/SeNPs) spectrum in Fig. 1 revealed numerous biochemical bonds/groups from both composing agents (NCT and MBS-SeNPs) that were present in the composites of (NCT/MBS/SeNPs), these groups are denoted in the figure by blue lines for groups derived from NCT and red lines for groups derived from MBS-SeNPs.

Ultrastructure assessment

For examining a nanoparticle’s charge, size, and morphology, zeta potential analysis and electron microscopy imaging were carried out (Table 1, Figs. 2 and 3). According to Table 1, using the DLS assessments of the zetasizer, the computed NCT ζ potential was highly positive (+ 39.62 mV) with a Ps range between 73.23 and 823.64 nm, while the MBS/SeNPs particles were negatively charged and much lower Ps (4.81–57.86 nm). Accordingly, when NCT was added to MBS/SeNPs particles in (T1), the charge increased to (− 12.45 mV), as NCT concentration grew, it increased to become moderately positive in (T2), then in (T3), where NCT concentration was highest, the ζ value became highly positive (+ 27.64 mV). The observed mean diameter of (T1), (T2), and (T3) was 204.13, 131.64, and 159.37, respectively. T2 represents the smallest particle size range (41.39–521.77 nm) and mean particle diameter (131.64 nm), with an equal quantity of NCT and MBS/SeNPs (1:1). In accordance with TEM (Fig. 2), the MBS-SeNPs spread uniformly and took on spherical forms, with Ps range between 3.6 and 42 nm. The uniform distribution of NPs and their stability with MBS during green synthesis were confirmed by the TEM images of the photosynthesized MBS-SeNPs. Also, the SEM (Fig. 3) images showed morphological characteristics revealed themselves as semispherical-shaped clusters with some aggregates present in addition to the individual particles with Ps range between 90.5 and 720 nm for T1 (A), and lower Ps range from 50.23 to 515.7 nm for T2 (B), and 40.7–670.8 nm for T3 (C), confirming the findings reported in Table 1. Table 1 Zeta potential and Ps distributions of produced nanomaterials and nanocomposites.

Nanoparticles	Particle size range (nm)	Mean diameter of particles (nm)	Zeta potential (mV)	
MBS	 > 1000	 > 1000	 − 11.39	
NCT	73.23–823.64	338.52	 + 39.62	
MBS/SeNPs	4.81–57.86	13.61	 − 14.61	
NCT/MBS/SeNPs (T1)	88.27–754.63	204.13	 − 12.45	
NCT/MBS/SeNPs (T2)	41.39–521.77	131.64	 + 10.82	
NCT/MBS/SeNPs (T3)	39.83–662.89	159.37	 + 27.64	

Figure 3 SEM image of biopolymers nanocomposites, with A standing for T1, B for T2, and C for T3.

In vitro determination of antibacterial activity

Qualitative and quantitative assays

The biopolymer nanocomposite's ability to eradicate both H. pylori strains (isolated and standard) in comparison to Amoxicillin (the standard anti-Helicobacter pylori) was assessed via MIC and ZOI tests. Furthermore, the ideal concentration for elimination was identified (Table 2). The isolated strain showed more sensitivity to the tested compounds than the standard strain based on MIC and ZOI resalted values. The compounds T1, T2, and T3 show the minimal MIC and broadest ZOI compared to NCT, MBS, and MBS/ SeNPs separately. The 1:1 NCT: MBS-SeNPs concentration in T2 outperformed the other two concentrations (T1 and T3) in terms of elimination of both isolated and standard H. pylori. Table 2 makes it evident that the third trial’s results, with a higher chitosan concentration, outperform the first one. This is because chitosan is positively charged, which makes it easier for it to attach to negatively charged cells. Nonetheless, MBS/SeNPs’s toxicity is still greater than NCT’s, based on this, the second trial gave better results, where the amount of chitosan is suitable for adhesion to cells, and the amount of selenium is appropriate for eliminating them. T2 also exhibits remarkable efficacy in comparison to the standard antibiotic (Amoxicillin), with 25.9 mm ZOI and 0.08 mg/L MIC against H. pylori I and 27.3 mm ZOI and 0.10 mg/L MIC against H. pylori ATCC-700824. Table 2 Antibacterial activity of biopolymers nanocomposites against H. pylori.

Compound	Helicobacter pylori I	Helicobacter pylori ATCC-700824	
	ZOI (mm)	MIC (mg/L)	ZOI (mm)	MIC (mg/L)	
MBS	ND	 > 25.0	ND	 > 25.0	
NCT	7.3	17.5	8.4	15.0	
MBS/SeNPs	13.6	7.5	15.1	5.0	
T1	19.1	2.5	19.9	2.0	
T2	25.9	0.08	27.3	0.10	
T3	22.2	0.19	23.1	0.16	
Amoxicillin	21.3	0.15	23.6	0.13	
*ZOI: mean diameter of inhibition zones in mm ± standard deviation; MIC: minimal inhibitory concentrations (mg/L).

Microscopic observation of treated H. pylori

The SEM micrograph (Fig. 4) displays how the nanoparticles stick to the bacteria’s external surface (red arrows indicate this), the core reason for this adhesion is due to chitosan molecules’ potent positive charge, which allows them to bind to the negatively charged cell surface, thereby supporting the biopolymers nanocomposites permeability inside the cell before being destroyed. Figure 4A showed H. pylori’s ordinary morphology, smooth and intact cell walls with multiple stuck nanoparticles on it when the exposure time first started, after exposure for 5 h (B), the coccoid form of H. pylori was observed clearly, which reflects the pressure to which the bacteria were exposed, the bacterial walls of both phenotype (bacilli and cocci) became rougher, puffy and less intact, other morphological abnormalities were also observed. When NCT/MBS/SeNPs exposure was extended to 10 h (Fig. 4C), the cells were completely lysed, ruptured, and released their internal components with the NPs sticking on them. These results demonstrate the strong effectiveness of NCT/MBS/SeNPs in eliminating the two H. pylori phenotypes.Figure 4 Micrograph by SEM of H. pylori after exposure to NCT/MBS/SeNPs for (A) 0 h, (B) 5 h, (C) 10 h. *Some connected NPs to the bacterial cells are indicated by red arrows. Blue arrows indicate other morphological forms of H. pylori.

Discussion

FTIR spectroscopy has proven to be a powerful tool to identify the extent to which components combine to generate new compounds with distinct features49. The primary distinguishing bands of the usual bands of natural chitosan are displayed in the FTIR spectrum of (NCT) (Fig. 1). STPP interactions with chitosan were primarily located in the range around 3422 cm−1, these interactions demonstrated a wider spacing and lower intensity compared to bulk Cht, which provides evidence for reduced − H bonding caused by the interactions with TPP cross-linkage30. Additionally, the functional group P=O which is located at 1036 cm−1 demonstrates the ionic bond-mediated cross-linkage between the phosphate groups of STPP and chitosan. These are all indications that a nanoparticle solution has been formed27,50. The ionic-gelation interaction used in the TPP cross-linking protocol to synthesize NCT was shown to be an effective operational protocol. The synthesized NCT with this protocol exhibited remarkable properties for practical application as nanocarriers for other bioactive constituents51. The MBS shows great potential for conjugating, reducing, and stabilizing SeNPs48. The band 3292 cm−1 in (MBS) spectrum shifts to 3415 cm−1 in (MBS/ SeNPs) spectrum indicating Se interaction with N–H and O–H groups, and the newly appeared 2915, 2850, and 1250 cm−1 bands, and the bands at 3000, 1749, 1554,1458, 1310, 1144, 702, 626, and 536 cm−1 that disappeared indicate the MBS role in SeNPs conjugation/reduction52. The noticeable changes in the (NCT/MBS/SeNPs) spectrum and the peaks that were different and shifted from those of their parent compounds (MBS/SeNPs and NCT), in addition to peaks that were detected from both spectrums reveal that there were biochemical and physical interactions occurring during MBS/SeNPs being trapped within NCT29.

The selection of electron microscopy approaches (e.g. TEM and SEM) based on the potency of TEM to appraise the actual precise size and shape of nanoparticles (especially the nanometals), whereas the SEM approach can effectually screen the surface morphology and alterations (particularly in nanopolymers and nanocomposites)25,31,36,41. Based on earlier research, the spherical shape observed in Fig. 2 is evidence of the presence of SeNPs. The Ps have a major impact on SeNPs’ biological activity53. The primary variables influencing the size of the particles are the host used in the synthesis process and the conditions of the synthesis. However, because SeNPs with a particle size of less than 200 nm easily infiltrate cells, participate in metabolic processes, and demonstrate increased biological activity, smaller nanoparticles are of the greatest interest for future biomedical usage53,54. This suggests that the Ps of SeNPs that MBS synthesizes (4.81–57.86 nm) is more than adequate for use as an antibiotic, as evidenced by comparison with previous studies that produced SeNPs with greater Ps29,53,55. According to Table 1, the sizes of MBS/SeNPs increased significantly after combining NCT in T1, T2, and T3, indicating their combination and integrations27. The data suggests that MBS/NCT/SeNPs tend to form aggregates rather than separate particles, resulting in a larger particle size range. The potential improvements or modifications to the experimental design that might address this in future studies could be suggested to employ ultra-sonication after the NCs preparation to disperse particles, adjust blending ratio of NCT to MBS-SeNPs for optimizing particles’ charges, and optimize the biosynthesis conditions (e.g. temperature, pH, stirring speed,…etc.)19,25,28,49,54.

Several fields, including biotechnology, food processing, pharmaceutics, and water treatment, have employed chitosan56. This biopolymer has also been applied as a strong antibiotic agent against bacteria and fungi57. The effectiveness of chitosan against Gram-negative bacteria is greater than Gram-positive58. One of the most contributing properties to chitosan’s antibacterial effect is the positive charges that possess on its surface. This makes it easier to attach to negatively charged cells and more effectively deliver active ingredients to them33,36. Chitosan gets significant advantages by being transformed from its basic form into nanoparticles since this enhances the surface area that interacts with bacteria and, thus, strengthens adhesion59. When looking for bioactive compounds that are more effective, less harmful, and less expensive, plants are the best option60. Broccoli’s antibacterial properties have been investigated by numerous scientists against Staphylococcus aureus, Salmonella typhimurium, Pseudomonas aeruginosa, Bacillus cereus, and Listeria monocytogenes, either with application of plain plant extract or the synthesized nanomaterial with extract61–64. Numerous studies have demonstrated that nano-selenium particles have greater toxicity against pathogens than nano-chitosan27,31,41, but it is less adhering to the surface of bacteria because of its negative charge according to24,31,52, which repels the negative charge of bacteria as well. Therefore, using chitosan loaded with nano-selenium particles gives the best outcomes, as shown in previous studies, where the positive chitosan sticks to the negative cell, and the selenium then kills it29,31,41.

The in vitro determination of anti H. pylori activity in current investigation involved the usage of different techniques to appraise the potency and actions of screened agents/NCs26,32,33. The qualitative “ZOI” approach gives direct and general reflections about the potency of antimicrobials toward microbial species; the quantitative “MIC” assay provides exact results about the required concentrations from each agent to suppress or kill the microorganism, whereas the SEM microscopic observations screens the action of antimicrobials to disfigure /distort bacterial cells after exposure35,36,41,58,59.

As we previously explained, the deadly effect of NCT, SeNPs, and MBS separately has been proven in many studies against different types of bacteria, whether Gram-negative or Gram-positive. Therefore, in this study, the effect of NCT/MBS/SeNPs was tested as an anti-H. pylori and its effectiveness was successfully proven.

Conclusion

This study constructed nanocomposites of NCT/MBS/SeNPs, in which the green synthesis of MBS resulted in the successful production of selenium nanoparticles with a particle size range of 4.81–57.86 nm. In three trials, chitosan was also employed at varying concentrations: (T1) with a 1:2 NCT ratio for MBS-SeNPs, (T2) with a 1:1 NCT ratio for MBS-SeNPs, and (T3) with a 2:1 NCT ratio for MBS-SeNPs. FTIR, zetasizer, SEM, and TEM were used to characterize the nanocomposites, and their effective synthesis was demonstrated. MIC, ZOI, and microscopic examination of treated bacteria were also used to assess its anti-H. pylori efficacy, with greater success favoring the (T2). From what was achieved, the effectiveness of NCT/MBS/SeNPs in eliminating H. pylori was well-proven. We advise employing NCT/MBS/SeNPs as a potent anti-H. pylori agent in light of the study’s findings and conclusion.

Supplementary Information

Supplementary Figures.

Supplementary Information

The online version contains supplementary material available at 10.1038/s41598-024-65762-2.

Acknowledgements

The author would like to thank the Deanship of Scientific Research at Shaqra University for supporting this work.

Author contributions

Conceptualization, A.A.S.A., A.A.T. and M.A.; methodology, A.A.S.A., A.A.T. and A.A.O.; software, M.A., S.H.M and F.M.A.; validation, A.I.A., A.A.O., M.A. and M.A.; formal analysis, A.A.O. and M.A.; investigation, A.A.S.A., A.A.T. and M.A.; resources, F.M.A. and S.H.M.; data curation, A.A.S.A., M.A. and A.I.A.; writing—original draft preparation, A.A.S.A., A.A.O. and A.A.T.; writing—review and editing, S.H.M. and A.A.T.; visualization, A.A.O. and F.M.A.; supervision, M.A., A.A.O. and A.A.T.; project administration, M.A. and F.M.A.; funding acquisition, A.I.A. and S.H.M. All authors have read and agreed to the published version of the manuscript.

Data availability

The data presented in this study are available on request from the corresponding author.

Competing interests

The authors declare no competing interests.

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

These authors contributed equally: Ahmed A. Tayel and Shaaban H. Moussa.
==== Refs
References

1. Burucoa C Axon A Epidemiology of Helicobacter pylori infection Helicobacter 2017 22 e12403 10.1111/hel.12403
Burucoa, C. & Axon, A. Epidemiology of Helicobacter pylori infection. Helicobacter 22, e12403 (2017).
2. Sathianarayanan S Ammanath AV Biswas R Anita B Sukumaran S Venkidasamy B A new approach against Helicobacter pylori using plants and its constituents: A review study Microb. Pathog. 2022 168 105594 10.1016/j.micpath.2022.105594 35605740
Sathianarayanan, S. et al. A new approach against Helicobacter pylori using plants and its constituents: A review study. Microb. Pathog. 168, 105594 (2022).35605740
3. Boyanova L Hadzhiyski P Gergova R Markovska R Evolution of Helicobacter pylori resistance to antibiotics: A topic of increasing concern Antibiotics 2023 12 2 332 10.3390/antibiotics12020332 36830243
Boyanova, L., Hadzhiyski, P., Gergova, R. & Markovska, R. Evolution of Helicobacter pylori resistance to antibiotics: A topic of increasing concern. Antibiotics 12(2), 332 (2023).36830243
4. Bücker R Azevedo-Vethacke M Groll C Garten D Josenhans C Suerbaum S Schreiber S Helicobacter pylori colonization critically depends on postprandial gastric conditions Sci. Rep. 2012 2 994 10.1038/srep00994 23251780
Bücker, R. et al. Helicobacter pylori colonization critically depends on postprandial gastric conditions. Sci. Rep. 2, 994 (2012).23251780
5. Jonaitis P Nyssen OP Saracino IM Comparison of the management of Helicobacter pylori infection between the older and younger European populations Sci. Rep. 2023 13 17235 10.1038/s41598-023-43287-4 37821503
Jonaitis, P., Nyssen, O. P. & Saracino, I. M. Comparison of the management of Helicobacter pylori infection between the older and younger European populations. Sci. Rep. 13, 17235 (2023).37821503
6. Charitos IA D’Agostino D Topi S Bottalico L 40 years of Helicobacter pylori: A revolution in biomedical thought Gastroenterol. Insights 2021 12 2 111 135 10.3390/gastroent12020011
Charitos, I. A., D’Agostino, D., Topi, S. & Bottalico, L. 40 years of Helicobacter pylori: A revolution in biomedical thought. Gastroenterol. Insights 12(2), 111–135 (2021).
7. Mazaheri Assadi M Chamanrokh P Whitehouse CA Huq A Methods for detecting the environmental coccoid form of Helicobacter pylori Public Health Front. 2015 3 138400 10.3389/fpubh.2015.00147
Mazaheri Assadi, M., Chamanrokh, P., Whitehouse, C. A. & Huq, A. Methods for detecting the environmental coccoid form of Helicobacter pylori. Public Health Front. 3, 138400 (2015).
8. Ierardi E Losurdo G Mileti A Paolillo R Giorgio F Principi M Di Leo A The puzzle of coccoid forms of Helicobacter pylori: Beyond basic science Antibiotics 2020 9 6 293 10.3390/antibiotics9060293 32486473
Ierardi, E. et al. The puzzle of coccoid forms of Helicobacter pylori: Beyond basic science. Antibiotics 9(6), 293 (2020).32486473
9. Krzyżek P Grande R Transformation of Helicobacter pylori into coccoid forms as a challenge for research determining activity of antimicrobial substances Pathogens 2020 9 3 184 10.3390/pathogens9030184 32143312
Krzyżek, P. & Grande, R. Transformation of Helicobacter pylori into coccoid forms as a challenge for research determining activity of antimicrobial substances. Pathogens 9(3), 184 (2020).32143312
10. Sasaki Y Abe Y Shoji M Mizumoto N Takeda H Oizumi H Yaoita T Sawada N Yamagishi K Saito E Watanabe M Ishizawa K Konta T Kayama T Tsugane S Ueno Y Inoue M Reliability of self-reported questionnaire for epidemiological investigation of Helicobacter pylori eradication in a population-based cohort study Sci. Rep. 2021 11 1 15605 10.1038/s41598-021-95124-1 34341428
Sasaki, Y. et al. Reliability of self-reported questionnaire for epidemiological investigation of Helicobacter pylori eradication in a population-based cohort study. Sci. Rep. 11(1), 15605 (2021).34341428
11. Hu Y Zhu Y Lu NH Recent progress in Helicobacter pylori treatment Chin. Med. J. 2020 133 03 335 343 10.1097/CM9.0000000000000618 31929363
Hu, Y., Zhu, Y. & Lu, N. H. Recent progress in Helicobacter pylori treatment. Chin. Med. J. 133(03), 335–343 (2020).31929363
12. Suzuki S Kusano C Horii T Ichijima R Ikehara H The ideal Helicobacter pylori treatment for the present and the future Digestion 2022 103 1 62 68 10.1159/000519413 34662879
Suzuki, S., Kusano, C., Horii, T., Ichijima, R. & Ikehara, H. The ideal Helicobacter pylori treatment for the present and the future. Digestion 103(1), 62–68 (2022).34662879
13. Mikhail CRG Abd El Maksoud Mohamed A Shaker OG El Desouky E Shalaby RH Frequency and risk factors of H. pylori infection among dental students: An observational cross-sectional study Sci. Rep. 2023 13 14264 10.1038/s41598-023-41246-7 37653065
Mikhail, C. R. G., Abd El Maksoud Mohamed, A., Shaker, O. G., El Desouky, E. & Shalaby, R. H. Frequency and risk factors of H. pylori infection among dental students: An observational cross-sectional study. Sci. Rep. 13, 14264 (2023).37653065
14. Bashir SK Khan MB Overview of Helicobacter pylori infection, prevalence, risk factors, and its prevention Adv. Gut Microbiome Res. 2023 2023 9747027 10.1155/2023/9747027
Bashir, S. K. & Khan, M. B. Overview of Helicobacter pylori infection, prevalence, risk factors, and its prevention. Adv. Gut Microbiome Res. 2023, 9747027 (2023).
15. Talebi Bezmin Abadi A Rizvanov AA Haertlé T Blatt NL World Health Organization report: Current crisis of antibiotic resistance J. Bionanosci. 2019 9 778 788 10.1007/s12668-019-00658-4
Talebi Bezmin Abadi, A., Rizvanov, A. A., Haertlé, T. & Blatt, N. L. World Health Organization report: Current crisis of antibiotic resistance. J. Bionanosci. 9, 778–788 (2019).
16. Alomar HA Fathallah N Abdel-Aziz MM Ibrahim TA Elkady WM Gc-ms profiling, anti-Helicobacter pylori, and anti-inflammatory activities of three apiaceous fruits’ essential oils Plants 2022 11 19 2617 10.3390/plants11192617 36235480
Alomar, H. A., Fathallah, N., Abdel-Aziz, M. M., Ibrahim, T. A. & Elkady, W. M. Gc-ms profiling, anti-Helicobacter pylori, and anti-inflammatory activities of three apiaceous fruits’ essential oils. Plants 11(19), 2617 (2022).36235480
17. Kawakami Y Oana K Hayama M Ota H Takeuchi M Miyashita K Matsuzawa T Kanaya K In vitro bactericidal activities of Japanese rice-fluid against Helicobacter pylori strains Int. J. Med. Sci. 2006 3 3 112 10.7150/ijms.3.112 16906220
Kawakami, Y. et al. In vitro bactericidal activities of Japanese rice-fluid against Helicobacter pylori strains. Int. J. Med. Sci. 3(3), 112 (2006).16906220
18. Lien HM Wu HY Hung CL Chen CJ Wu CL Chen KW Huang CL Chang SJ Chen CC Lin HJ Lai CH Antibacterial activity of ovatodiolide isolated from Anisomeles indica against Helicobacter pylori Sci. Rep. 2019 9 4205 10.1038/s41598-019-40735-y 30862888
Lien, H. M. et al. Antibacterial activity of ovatodiolide isolated from Anisomeles indica against Helicobacter pylori. Sci. Rep. 9, 4205 (2019).30862888
19. Taheri A Razavi SM Fabrication of cress seed gum nanoparticles, an anionic polysaccharide, using desolvation technique: An optimization study J. Bionanosci. 2015 5 104 116 10.1007/s12668-015-0169-6
Taheri, A. & Razavi, S. M. Fabrication of cress seed gum nanoparticles, an anionic polysaccharide, using desolvation technique: An optimization study. J. Bionanosci. 5, 104–116 (2015).
20. Tosif MM Najda A Bains A Kaushik R Dhull SB Chawla P Walasek-Janusz M A comprehensive review on plant-derived mucilage: Characterization, functional properties, applications, and its utilization for nanocarrier fabrication Polymers 2021 13 7 1066 10.3390/polym13071066 33800613
Tosif, M. M. et al. A comprehensive review on plant-derived mucilage: Characterization, functional properties, applications, and its utilization for nanocarrier fabrication. Polymers 13(7), 1066 (2021).33800613
21. Thery T Lynch KM Zannini E Arendt EK Isolation, characterisation and application of a new antifungal protein from broccoli seeds–New food preservative with great potential Food Control 2020 117 107356 10.1016/j.foodcont.2020.107356
Thery, T., Lynch, K. M., Zannini, E. & Arendt, E. K. Isolation, characterisation and application of a new antifungal protein from broccoli seeds–New food preservative with great potential. Food Control 117, 107356 (2020).
22. López-Cervantes J Tirado-Noriega LG Sánchez-Machado DI Campas-Baypoli ON Cantú-Soto EU Núñez-Gastélum JA Biochemical composition of broccoli seeds and sprouts at different stages of seedling development Int. J. Food Sci. Technol. 2013 48 11 2267 2275 10.1111/ijfs.12213
López-Cervantes, J. et al. Biochemical composition of broccoli seeds and sprouts at different stages of seedling development. Int. J. Food Sci. Technol. 48(11), 2267–2275 (2013).
23. Abdelsalam A El-Sayed H Hamama HM Morad MY Aloufi AS Abd El-Hameed RM Biogenic selenium nanoparticles: Anticancer, antimicrobial, insecticidal properties and their impact on soybean (Glycine max L.) seed germination and seedling growth Biology 2023 12 11 1361 10.3390/biology12111361 37997960
Abdelsalam, A. et al. Biogenic selenium nanoparticles: Anticancer, antimicrobial, insecticidal properties and their impact on soybean (Glycine max L.) seed germination and seedling growth. Biology 12(11), 1361 (2023).37997960
24. ElSaied BE Diab AM Tayel AA Alghuthaymi MA Moussa SH Potent antibacterial action of phycosynthesized selenium nanoparticles using Spirulina platensis extract Green Process. Synth. 2021 10 1 49 60 10.1515/gps-2021-0005
ElSaied, B. E., Diab, A. M., Tayel, A. A., Alghuthaymi, M. A. & Moussa, S. H. Potent antibacterial action of phycosynthesized selenium nanoparticles using Spirulina platensis extract. Green Process. Synth. 10(1), 49–60 (2021).
25. Shehata NS Elwakil BH Elshewemi SS Ghareeb DA Olama ZA Selenium nanoparticles coated bacterial polysaccharide with potent antimicrobial and anti-lung cancer activities Sci. Rep. 2023 13 1 21871 10.1038/s41598-023-48921-9 38072846
Shehata, N. S., Elwakil, B. H., Elshewemi, S. S., Ghareeb, D. A. & Olama, Z. A. Selenium nanoparticles coated bacterial polysaccharide with potent antimicrobial and anti-lung cancer activities. Sci. Rep. 13(1), 21871 (2023).38072846
26. Serov DA Khabatova VV Vodeneev V Li R Gudkov SV A review of the antibacterial, fungicidal and antiviral properties of selenium nanoparticles Materials 2023 16 15 5363 10.3390/ma16155363 37570068
Serov, D. A., Khabatova, V. V., Vodeneev, V., Li, R. & Gudkov, S. V. A review of the antibacterial, fungicidal and antiviral properties of selenium nanoparticles. Materials 16(15), 5363 (2023).37570068
27. Salem MF Abd-Elraoof WA Tayel AA Alzuaibr FM Abonama OM Antifungal application of biosynthesized selenium nanoparticles with pomegranate peels and nanochitosan as edible coatings for citrus green mold protection J. Nanobiotechnology 2022 20 1 182 10.1186/s12951-022-01393-x 35392922
Salem, M. F., Abd-Elraoof, W. A., Tayel, A. A., Alzuaibr, F. M. & Abonama, O. M. Antifungal application of biosynthesized selenium nanoparticles with pomegranate peels and nanochitosan as edible coatings for citrus green mold protection. J. Nanobiotechnology 20(1), 182 (2022).35392922
28. Ikram M Javed B Raja NI Mashwani ZUR Biomedical potential of plant-based selenium nanoparticles: A comprehensive review on therapeutic and mechanistic aspects Int. J. Nanomed. 2021 2021 16 249 268 10.2147/IJN.S295053
Ikram, M., Javed, B., Raja, N. I. & Mashwani, Z. U. R. Biomedical potential of plant-based selenium nanoparticles: A comprehensive review on therapeutic and mechanistic aspects. Int. J. Nanomed. 2021(16), 249–268 (2021).
29. Alghuthaymi MA Diab AM Elzahy AF Mazrou KE Tayel AA Moussa SH Green biosynthesized selenium nanoparticles by cinnamon extract and their antimicrobial activity and application as edible coatings with nano-chitosan J. Food Qual. 2021 2021 6670709 10.1155/2021/6670709
Alghuthaymi, M. A. et al. Green biosynthesized selenium nanoparticles by cinnamon extract and their antimicrobial activity and application as edible coatings with nano-chitosan. J. Food Qual. 2021, 6670709 (2021).
30. Tayel AA Elsayes NA Zayed MM Alsieni MA Alatawi FA Alalawy AI Diab AM Powerful antibacterial nanocomposites from Corallina officinalis-mediated nanometals and chitosan nanoparticles against fish-borne pathogens Green Process. Synth. 2023 12 1 20230042 10.1515/gps-2023-0042
Tayel, A. A. et al. Powerful antibacterial nanocomposites from Corallina officinalis-mediated nanometals and chitosan nanoparticles against fish-borne pathogens. Green Process. Synth. 12(1), 20230042 (2023).
31. El-Sherbiny MM Orif MI El-Hefnawy ME Alhayyani S Tayel AA Fabrication of bioactive nanocomposites from chitosan, cress mucilage, and selenium nanoparticles with powerful antibacterial and anticancerous actions Front. Microbial. 2023 14 1210780 10.3389/fmicb.2023.1210780
El-Sherbiny, M. M., Orif, M. I., El-Hefnawy, M. E., Alhayyani, S. & Tayel, A. A. Fabrication of bioactive nanocomposites from chitosan, cress mucilage, and selenium nanoparticles with powerful antibacterial and anticancerous actions. Front. Microbial. 14, 1210780 (2023).
32. Quinto EJ Caro I Villalobos-Delgado LH Mateo J De-Mateo-Silleras B Redondo-Del-Río MP Food safety through natural antimicrobials Antibiotics 2019 8 4 208 10.3390/antibiotics8040208 31683578
Quinto, E. J. et al. Food safety through natural antimicrobials. Antibiotics 8(4), 208 (2019).31683578
33. Rozman NAS Tong WY Leong CR Tan WN Hasanolbasori MA Abdullah SZ Potential antimicrobial applications of chitosan nanoparticles (ChNP) J. Microbiol. Biotechnol. 2019 29 1009 1013 10.4014/jmb.1904.04065 31288302
Rozman, N. A. S. et al. Potential antimicrobial applications of chitosan nanoparticles (ChNP). J. Microbiol. Biotechnol. 29, 1009–1013 (2019).31288302
34. Jeong YJ Kim HE Han SJ Choi JS Antibacterial and antibiofilm activities of cinnamon essential oil nanoemulsion against multi-species oral biofilms Sci. Rep. 2021 11 1 5911 10.1038/s41598-021-85375-3 33723345
Jeong, Y. J., Kim, H. E., Han, S. J. & Choi, J. S. Antibacterial and antibiofilm activities of cinnamon essential oil nanoemulsion against multi-species oral biofilms. Sci. Rep. 11(1), 5911 (2021).33723345
35. Kong M Chen XG Xing K Park HJ Antimicrobial properties of chitosan and mode of action: a state of the art review Int. J. Food Microbiol. 2010 144 1 51 63 10.1016/j.ijfoodmicro.2010.09.012 20951455
Kong, M., Chen, X. G., Xing, K. & Park, H. J. Antimicrobial properties of chitosan and mode of action: a state of the art review. Int. J. Food Microbiol. 144(1), 51–63 (2010).20951455
36. Muthusankar E Vignesh Kumar S Rajagopalan N Ragupathy D Synthesis and characterization of co-polymer nanocomposite film and its enhanced antimicrobial behavior J. Bionanosci. 2018 8 4 1008 1013 10.1007/s12668-018-0564-x
Muthusankar, E., Vignesh Kumar, S., Rajagopalan, N. & Ragupathy, D. Synthesis and characterization of co-polymer nanocomposite film and its enhanced antimicrobial behavior. J. Bionanosci. 8(4), 1008–1013 (2018).
37. Hasna B Houari H Koula D Marina S Emilia U Assia B In vitro and in vivo study of combined effect of some Algerian medicinal plants and probiotics against Helicobacter pylori Microorganisms 2023 11 5 1242 10.3390/microorganisms11051242 37317215
Hasna, B. et al. In vitro and in vivo study of combined effect of some Algerian medicinal plants and probiotics against Helicobacter pylori. Microorganisms 11(5), 1242 (2023).37317215
38. Akhtereeva AR Morozova LG Faizullina RA Ivanovskaya KA Pozdeev OK Valeeva IK Abdulkhakov SR Antibiotic susceptibility assessment of Helicobacter pylori isolates by disk-diffusion method J. Bionanosci. 2018 8 3 930 934 10.1007/s12668-018-0527-2
Akhtereeva, A. R. et al. Antibiotic susceptibility assessment of Helicobacter pylori isolates by disk-diffusion method. J. Bionanosci. 8(3), 930–934 (2018).
39. Yahya R Al-Rajhi AM Alzaid SZ Al Abboud MA Almuhayawi MS Al Jaouni SK Ismail KS Abdelghany TM Molecular docking and efficacy of Aloe vera gel based on chitosan nanoparticles against Helicobacter pylori and its antioxidant and anti-inflammatory activities Polymers 2022 14 15 2994 10.3390/polym14152994 35893958
Yahya, R. et al. Molecular docking and efficacy of Aloe vera gel based on chitosan nanoparticles against Helicobacter pylori and its antioxidant and anti-inflammatory activities. Polymers 14(15), 2994 (2022).35893958
40. Queiroz MF Teodosio Melo KR Sabry DA Sassaki GL Rocha HAO Does the use of chitosan contribute to oxalate kidney stone formation? Mar. Drugs 2014 13 1 141 158 10.3390/md13010141 25551781
Queiroz, M. F., Teodosio Melo, K. R., Sabry, D. A., Sassaki, G. L. & Rocha, H. A. O. Does the use of chitosan contribute to oxalate kidney stone formation?. Mar. Drugs 13(1), 141–158 (2014).25551781
41. Abd-Elraoof WA Tayel AA Shaymaa W Abukhatwah OMW Diab AM Abonama OM Assas MA Abdella A Characterization and antimicrobial activity of a chitosan-selenium nanocomposite biosynthesized using Posidonia oceanica RSC Adv. 2023 13 37 26001 26014 10.1039/D3RA04288J 37664190
Abd-Elraoof, W. A. et al. Characterization and antimicrobial activity of a chitosan-selenium nanocomposite biosynthesized using Posidonia oceanica. RSC Adv. 13(37), 26001–26014 (2023).37664190
42. Vijayalakshmi K Devi BM Sudha PN Venkatesan J Anil SJJNN Synthesis, characterization and applications of nanochitosan/sodium alginate/microcrystalline cellulose film J. Nanomed. Nanotechnol. 2016 7 419 2
Vijayalakshmi, K., Devi, B. M., Sudha, P. N., Venkatesan, J. & Anil, S. J. J. N. N. Synthesis, characterization and applications of nanochitosan/sodium alginate/microcrystalline cellulose film. J. Nanomed. Nanotechnol. 7(419), 2 (2016).
43. Talebi A Labbaf S Karimzadeh F Polycaprolactone/chitosan/polypyrrole conductive biocomposite nanofibrous scaffold for biomedical applications Polym. Compos. 2020 41 2 645 652 10.1002/pc.25395
Talebi, A., Labbaf, S. & Karimzadeh, F. Polycaprolactone/chitosan/polypyrrole conductive biocomposite nanofibrous scaffold for biomedical applications. Polym. Compos. 41(2), 645–652 (2020).
44. Osuntokun J Onwudiwe DC Ebenso EE Green synthesis of ZnO nanoparticles using aqueous Brassica oleracea L. var. italica and the photocatalytic activity Green Chem. Lett. Rev. 2019 12 4 444 457 10.1080/17518253.2019.1687761
Osuntokun, J., Onwudiwe, D. C. & Ebenso, E. E. Green synthesis of ZnO nanoparticles using aqueous Brassica oleracea L. var. italica and the photocatalytic activity. Green Chem. Lett. Rev. 12(4), 444–457 (2019).
45. Wahid A Giri SK Kate A Tripathi MK Kumar M Enhancing phytochemical parameters in broccoli through vacuum impregnation and their prediction with comparative ANN and RSM models Sci. Rep. 2023 13 1 15579 10.1038/s41598-023-41930-8 37730709
Wahid, A., Giri, S. K., Kate, A., Tripathi, M. K. & Kumar, M. Enhancing phytochemical parameters in broccoli through vacuum impregnation and their prediction with comparative ANN and RSM models. Sci. Rep. 13(1), 15579 (2023).37730709
46. Vicas SI Cavalu S Laslo V Tocai M Costea TO Moldovan L Growth, photosynthetic pigments, phenolic, glucosinolates content and antioxidant capacity of broccoli sprouts in response to nanoselenium particles supply Not. Bot. Horti. Agrobot. 2019 47 3 821 828
Vicas, S. I. et al. Growth, photosynthetic pigments, phenolic, glucosinolates content and antioxidant capacity of broccoli sprouts in response to nanoselenium particles supply. Not. Bot. Horti. Agrobot. 47(3), 821–828 (2019).
47. Radünz M Hackbart HCDS Bona NP Pedra NS Hoffmann JF Stefanello FM Zavareze EDR Glucosinolates and phenolic compounds rich broccoli extract: Encapsulation by electrospraying and antitumor activity against glial tumor cells Colloids Surf. B 2020 192 111020 10.1016/j.colsurfb.2020.111020
Radünz, M. et al. Glucosinolates and phenolic compounds rich broccoli extract: Encapsulation by electrospraying and antitumor activity against glial tumor cells. Colloids Surf. B 192, 111020 (2020).
48. Dhanraj G Rajeshkumar S Anticariogenic effect of selenium nanoparticles synthesized using Brassica oleracea J. Nanomater. 2021 2021 1 9 10.1155/2021/8115585
Dhanraj, G. & Rajeshkumar, S. Anticariogenic effect of selenium nanoparticles synthesized using Brassica oleracea. J. Nanomater. 2021, 1–9 (2021).
49. Gür E Altinisik A Yurdakoc K Preparation and characterization of chitosan/sepiolite bionanocomposites for tetracycline release Polym. Compos. 2017 38 9 1810 1818 10.1002/pc.23751
Gür, E., Altinisik, A. & Yurdakoc, K. Preparation and characterization of chitosan/sepiolite bionanocomposites for tetracycline release. Polym. Compos. 38(9), 1810–1818 (2017).
50. Rosyada A Sunarharum WB Waziiroh E Characterization of chitosan nanoparticles as an edible coating material Earth Environ. Sci. 2019 230 012043
Rosyada, A., Sunarharum, W. B. & Waziiroh, E. Characterization of chitosan nanoparticles as an edible coating material. Earth Environ. Sci. 230, 012043 (2019).
51. Amer ET Tayel AA Maksoud AIAE Alsieni M Gad HA Assas MA Elebeedy D Antibacterial potentialities of chitosan nanoparticles loaded with salvianolic acid B and tanshinone IIA J. Bionanosci. 2023
Amer, E. T. et al. Antibacterial potentialities of chitosan nanoparticles loaded with salvianolic acid B and tanshinone IIA. J. Bionanosci.10.1007/s12668-023-01263-2 (2023).
52. Al-Saggaf MS Tayel AA Ghobashy MO Alotaibi MA Alghuthaymi MA Moussa SH Phytosynthesis of selenium nanoparticles using the costus extract for bactericidal application against foodborne pathogens Green Process. Synth. 2020 9 1 477 487 10.1515/gps-2020-0038
Al-Saggaf, M. S. et al. Phytosynthesis of selenium nanoparticles using the costus extract for bactericidal application against foodborne pathogens. Green Process. Synth. 9(1), 477–487 (2020).
53. Xu D Yang L Wang Y Wang G Rensing C Zheng S Proteins enriched in charged amino acids control the formation and stabilization of selenium nanoparticles in Comamonas testosteroni S44 Sci. Rep. 2018 8 1 4766 10.1038/s41598-018-23295-5 29555951
Xu, D. et al. Proteins enriched in charged amino acids control the formation and stabilization of selenium nanoparticles in Comamonas testosteroni S44. Sci. Rep. 8(1), 4766 (2018).29555951
54. Mikhailova EO Selenium Nanoparticles: Green synthesis and biomedical application Molecules 2023 28 24 8125 10.3390/molecules28248125 38138613
Mikhailova, E. O. Selenium Nanoparticles: Green synthesis and biomedical application. Molecules 28(24), 8125 (2023).38138613
55. Shehab MM Elbialy ZI Tayel AA Moussa SH Al-Hawary II Quality boost and shelf-life prolongation of African catfish fillet using Lepidium sativum mucilage extract and selenium nanoparticles J. Food Qual. 2022 2022 9063801 10.1155/2022/9063801
Shehab, M. M., Elbialy, Z. I., Tayel, A. A., Moussa, S. H. & Al-Hawary, I. I. Quality boost and shelf-life prolongation of African catfish fillet using Lepidium sativum mucilage extract and selenium nanoparticles. J. Food Qual. 2022, 9063801 (2022).
56. Pasban S Raissi H Nanotechnology-based approaches for targeting and delivery of drugs via Hexakis (m-PE) macrocycles Sci. Rep. 2021 11 1 8256 10.1038/s41598-021-87011-6 33859230
Pasban, S. & Raissi, H. Nanotechnology-based approaches for targeting and delivery of drugs via Hexakis (m-PE) macrocycles. Sci. Rep. 11(1), 8256 (2021).33859230
57. Maurya AK de Souza FM Dawsey T Gupta RK Biodegradable polymers and composites: Recent development and challenges Polym. Compos. 2023 45 4 2896 2918 10.1002/pc.28023
Maurya, A. K., de Souza, F. M., Dawsey, T. & Gupta, R. K. Biodegradable polymers and composites: Recent development and challenges. Polym. Compos. 45(4), 2896–2918 (2023).
58. Ke CL Deng FS Chuang CY Lin CH Antimicrobial actions and applications of chitosan Polymers 2021 13 6 904 10.3390/polym13060904 33804268
Ke, C. L., Deng, F. S., Chuang, C. Y. & Lin, C. H. Antimicrobial actions and applications of chitosan. Polymers 13(6), 904 (2021).33804268
59. Sharma R Jafari SM Sharma S Antimicrobial bio-nanocomposites and their potential applications in food packaging Food Control 2020 112 107086 10.1016/j.foodcont.2020.107086
Sharma, R., Jafari, S. M. & Sharma, S. Antimicrobial bio-nanocomposites and their potential applications in food packaging. Food Control 112, 107086 (2020).
60. Tayel AA Shaban SM Moussa SH Elguindy NM Diab AM Mazrou KE Ghanem RA El-Sabbagh SM Bioactivity and application of plant seeds’ extracts to fight resistant strains of Staphylococcus aureus Ann. Agric. Sci. 2018 63 1 47 53 10.1016/j.aoas.2018.04.006
Tayel, A. A. et al. Bioactivity and application of plant seeds’ extracts to fight resistant strains of Staphylococcus aureus. Ann. Agric. Sci. 63(1), 47–53 (2018).
61. Ansar S Tabassum H Aladwan NSM Ali MN Almaarik B AlMahrouqi S Abudawood M Banu N Alsubki R Eco friendly silver nanoparticles synthesis by Brassica oleracea and its antibacterial, anticancer and antioxidant properties Sci. Rep. 2020 10 18564 10.1038/s41598-020-74371-8 33122798
Ansar, S. et al. Eco friendly silver nanoparticles synthesis by Brassica oleracea and its antibacterial, anticancer and antioxidant properties. Sci. Rep. 10, 18564 (2020).33122798
62. Hu WS Min Nam D Kim JS Koo OK Synergistic anti-biofilm effects of Brassicaceae plant extracts in combination with proteinase K against Escherichia coli O157:H7 Sci. Rep. 2020 10 21090 10.1038/s41598-020-77868-4 33273563
Hu, W. S., Min Nam, D., Kim, J. S. & Koo, O. K. Synergistic anti-biofilm effects of Brassicaceae plant extracts in combination with proteinase K against Escherichia coli O157:H7. Sci. Rep. 10, 21090 (2020).33273563
63. Pacheco-Cano RD Salcedo-Hernández R Casados-Vázquez LE Wrobel K Bideshi DK Barboza-Corona JE Class I defensins (BraDef) from broccoli (Brassica oleracea var. italica) seeds and their antimicrobial activity World J. Microbiol. Biotechnol. 2020 36 1 12 10.1007/s11274-020-2807-6
Pacheco-Cano, R. D. et al. Class I defensins (BraDef) from broccoli (Brassica oleracea var. italica) seeds and their antimicrobial activity. World J. Microbiol. Biotechnol. 36, 1–12 (2020).
64. Zhang YM Ye DX Liu Y Zhang XY Zhou YL Zhang L Yang XL Peptides, new tools for plant protection in eco-agriculture Adv. Agrochem. 2023 2 1 58 78 10.1016/j.aac.2023.01.003
Zhang, Y. M. et al. Peptides, new tools for plant protection in eco-agriculture. Adv. Agrochem. 2(1), 58–78 (2023).
